The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors

por Rodriguez, Andrew, Kamiya-Matsuoka, Carlos, Majd, Nazanin K.
Publicado 2023

Preclinical Models of Low-Grade Gliomas

por Dasgupta, Pushan, Balasubramanyian, Veerakumar, de Groot, John F., Majd, Nazanin K.
Publicado 2023

Recent Therapeutic Advances in Pituitary Carcinoma

por Robertson, Ian J., Gregory, Timothy A., Waguespack, Steven G., Penas-Prado, Marta, Majd, Nazanin K.
Publicado 2022

The promise of DNA damage response inhibitors for the treatment of glioblastoma

por Majd, Nazanin K, Yap, Timothy A, Koul, Dimpy, Balasubramaniyan, Veerakumar, Li, Xiaolong, Khan, Sabbir, Gandy, Katilin S, Yung, W K Alfred, de Groot, John F
Publicado 2021

Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells

por Khan, Sabbir, Mahalingam, Rajasekaran, Sen, Shayak, Martinez-Ledesma, Emmanuel, Khan, Arshad, Gandy, Kaitlin, Lang, Frederick F., Sulman, Erik P., Alfaro-Munoz, Kristin D., Majd, Nazanin K., Balasubramaniyan, Veerakumar, de Groot, John F.
Publicado 2021

A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram

por Ferguson, Sherise D, Hodges, Tiffany R, Majd, Nazanin K, Alfaro-Munoz, Kristin, Al-Holou, Wajd N, Suki, Dima, de Groot, John F, Fuller, Gregory N, Xue, Lee, Li, Miao, Jacobs, Carmen, Rao, Ganesh, Colen, Rivka R, Xiu, Joanne, Verhaak, Roel, Spetzler, David, Khasraw, Mustafa, Sawaya, Raymond, Long, James P, Heimberger, Amy B
Publicado 2020

A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma

por de Groot, John, Ott, Martina, Wei, Jun, Kassab, Cynthia, Fang, Dexing, Najem, Hinda, O'Brien, Barbara, Weathers, Shiao-Pei, Matsouka, Carlos Kamiya, Majd, Nazanin K, Harrison, Rebecca A, Fuller, Gregory N, Huse, Jason T, Long, James P, Sawaya, Raymond, Rao, Ganesh, MacDonald, Tobey J, Priebe, Waldemar, DeCuypere, Michael, Heimberger, Amy B
Publicado 2022

Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience

por Gregory, Timothy A, Mastall, Maximilian, Lin, Heather, Hess, Kenneth R, Yuan, Ying, Martin-Bejarano Garcia, Manuela, Fuller, Gregory N, Alfaro, Kristin D, Gule-Monroe, Maria K, Huse, Jason T, Khatua, Soumen, Rao, Ganesh, Sandberg, David I, Wefel, Jeffrey S, Yeboa, Debra N, Paulino, Arnold C, McGovern, Susan L, Zaky, Wafik, Mahajan, Anita, Suki, Dima, Weathers, Shiao-Pei, Harrison, Rebecca A, de Groot, John F, Puduvalli, Vinay K, Penas-Prado, Marta, Majd, Nazanin K
Publicado 2023

Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience

por Majd, Nazanin K, Mastall, Maximilan, Lin, Heather, Dibaj, Seyede Shiva, Hess, Kenneth R, Yuan, Ying, Garcia, Manuela Martin-Bejarano, Fuller, Gregory N, Alfaro, Kristin D, Gule-Monroe, Maria K, Huse, Jason T, Khatua, Soumen, Rao, Ganesh, Sandberg, David I, Wefel, Jeffrey S, Yeboa, Debra N, Paulino, Arnold C, McGovern, Susan L, Zaky, Wafik, Mahajan, Anita, Suki, Dima, Weathers, Shiao-Pei, Harriso, Rebecca A, De Groo, John F, Puduvalli, Vinay K, Penas-Prado, Marta
Publicado 2021